4个护工24小时陪护，用眼控仪100分钟回答3个问题，对话渐冻症抗争者蔡磊

Core Insights - The "Jianyu Mutual Aid Home" led by Cai Lei has established an unprecedented research collaboration network for ALS, resulting in nearly 100 research projects and 15 drug pipelines achieving clinical translation by the end of 2025 [1][16] - Cai Lei emphasizes that the advantages of ALS patients are often overlooked, stating that funding is not the primary issue, but rather the lack of advocates to drive research forward [2][18] - The team has made significant progress in ALS drug research, with over 18,000 registered patients and collaborations with more than 60 top research teams globally, leading to multiple clinical trials [16][17] Research Collaboration Network - The "Jianyu Mutual Aid Home" has created a unique ALS research collaboration network, achieving more fruitful results in 2025 compared to previous years [1] - The team has engaged in deep collaborations with over 50 biotech companies and numerous hospitals, facilitating the transition of research from basic mechanisms to clinical trials [16][17] Patient-Centric Innovation Framework - Cai Lei aims to create a patient-centered innovation framework for rare diseases, highlighting the significant yet often ignored advantages that patients possess in the research field [2][3] - The framework emphasizes the need for more individuals to advocate for ALS research, as financial resources are not the main barrier [18][19] Clinical Trial Progress - In 2025, the team successfully initiated several clinical trials, including projects evaluating the safety and efficacy of various treatments for ALS [17] - Notable projects include the evaluation of RAG-17 and ALTO01, which have entered different phases of clinical trials [17] AI Research Development - The "Jianyu Mutual Aid Home" has made a critical leap in developing an "ALS AI Research Brain," marking the initial formation of a new research paradigm centered on causal reasoning and human-machine collaboration [20] - The team plans to continue enhancing AI-assisted cognitive capabilities in 2026 to further advance ALS research [20]